Medivation (MDVN) – Insiders' Blog
-
Medivation (MDVN) Drops Lower Ahead of Q2 Results, Now Negative on Session
-
Medivation (MDVN) Hits Century Mark
-
Medivation (MDVN) Ripe for the Picking on Expected Enzalutamide Approval
-
Medivation (MDVN) Target of Negative TheStreetSweeper Article
-
Medivation (MDVN) Surges On Pfizer Deal
-
Following Today's Kosan (KOSN) Buyout, Investors Look for Next Biotech Deal
Back to MDVN Stock Lookup